Articles on BioNTech
Displaying all articles
The UK government announced that it is partnering with BioNTech to trial personalised cancer vaccines.
Moves by Moderna and BioNTech to make vaccines themselves in African countries signal that the companies aren’t considering licensing its technology to a third party for local manufacture.
The type of deep-tech ventures behind mRNA vaccines are key to economic prosperity and sustainable development.
With the vaccines now being administered at sites around the US, it is important to address misinformation surrounding the effort.
The side effects of new SARS-CoV-2 vaccines are a result of immune system activation. While uncomfortable, they are both normal and expected. They are a sign that the vaccine is working.
Because Pfizer-BioNTech and Moderna vaccines have been developed in record time, many wonder whether companies cut corners or compromised safety.
There are two new COVID-19 vaccines that appear to be more than 90% effective. But what are these vaccines, and how are they different from those used previously?
Interim analysis of trial data isn’t unusual – but leaves us with many things we still need to find out.
Vaccine development is usually a long process. The coronavirus pandemic is forcing researchers to innovate and test potential vaccines faster than ever before.








